ArticleArchives of medical science : AMS2026
Continuous glucose monitoring (CGM) systems in Poland, Europe, and beyond in 2025: principles, available technologies, and future perspectives.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, continuous glucose monitoring (CGM) systems have become increasingly common and more widely available for people with diabetes. A variety of devices appearing on the market, together with their increasing integration with other tools (insulin pumps, watches, and smartphone applications), require medical personnel to have a solid basic knowledge of CGMs, continuous follow-up, updated expertise extending beyond the local market, and a future-oriented perspective. Additionally, low-quality products without proper evaluation, which do not meet the standards established by diabetes societies, become available to patients. To provide an extended background on CGM technology principles, basic knowledge of results presentation, and interpretation according to recommendations, this review presents the most common devices, along with a cost-effectiveness analysis and a critical assessment. Furthermore, future perspectives are discussed, including AI technologies and modern solutions to enhance user comfort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.